CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

本文聚焦于豆科植物、根瘤菌（Rhizobium）和丛枝菌根真菌（AM 真菌）的共生关系，探讨其在减轻重金属污染污水污泥影响方面的作用。研究发现，这种共生能促进植物生长、提高养分吸收，为植物修复提供新方向，对农业可持续发展意义重大。 ### 1. 引言 豆科 ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Three genetically engineered wolves that may ...

The CRISPR Market had an estimated market share worth USD 3.4 billion in 2023, and it is predicted to reach a global market valuation of USD 17.8 billion by 2034, growing at a CAGR of 16.1% from 2024 ...

REDWOOD CITY, Calif., April 8, 2025 /PRNewswire/ -- Synthego and Vita Therapeutics, Inc. today announced a licensing agreement to integrate Synthego's high-fidelity hfCas12Max CRISPR system into ...

Key Laboratory of Quality and Safety Control of Citrus Fruits, Ministry of Agriculture and Rural Affairs, Southwest University, Chongqing 400712, P.R. China National Citrus Engineering Research Center ...

In a secret location in the United States, two white wolves are lounging in the grass in a sunny, roughly one-acre enclosure. It’s early spring and a chill wind blows through bare trees nearby.

CRISPR Therapeutics has a 12-month low of $30.96 and a 12-month high of $67.88. CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) last posted its quarterly earnings data on Tuesday, February 11th.

To achieve its goal, the company essentially created a hybrid genome using CRISPR technology to cut away certain gray wolf gene variants and replace them with traits associated with dire wolves ...

Washington: A revolution is underway in gene editing-- and at its forefront is David Liu, an American molecular biologist whose pioneering work is rewriting the building blocks of life with ...